— Know what they know.
Not Investment Advice

CYC.AX ASX

Cyclopharm Limited
1W: -2.2% 1M: -13.7% 3M: -4.3% YTD: -52.7% 1Y: -53.9% 3Y: -83.4% 5Y: -82.8%
A$0.45 ($0.31)
+0.01 (+1.14%)
 
Weekly Expected Move ±9.6%
A$0 A$0 A$0 A$0 A$1
ASX · Healthcare · Medical - Devices · Tech Score Sell · Power 37 · A$55.3M mcap · 65M float · 0.187% daily turnover

📊 Key Metrics

TTM
A$64M
Revenue
+27.4% YoY
A$-32M
Net Income
-95.0% YoY
A$-34M
Free Cash Flow
-65.5% YoY
-0.1%
Gross Margin
-48.0%
Op. Margin
-50.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-79.8%
ROA-55.7%
ROIC-118.1%

Valuation

P/E-2.8
P/B1.7
EV/EBITDA-1.7

Leverage

Debt/Equity0.24
Current Ratio3.37
Interest Cov.-38.1x

Quality Scores

Piotroski F3/9
Altman Z-0.55
Beneish M45.63

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms